Anyone newly diagnosed with Crohn's disease likely has a lot of questions – and probably some anxiety – about having a chronic ailment for which there's no cure.
Cedars-Sinai investigators have identified a genetic variant that increases people's risk of developing perianal Crohn's disease, the most debilitating manifestation of Crohn's disease.
The risk of developing lymphoma is slightly elevated in inflammatory bowel disease (IBD) and has increased in recent years in patients with Crohn's disease, report researchers from Karolinska Institutet in a study published in Clinical Gastroenterology and Hepatology.
Merck & Co have announced that they will purchase California-based biotechnology company Prometheus Biosciences for some $10.8 billion, in a bid to enlarge its presence in the immunology field
Merck & Co have announced that they will purchase California-based biotechnology company Prometheus Biosciences for some $10.8 billion, in a bid to enlarge its presence in the immunology field